Creative Planning
LABD icon

Creative Planning’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Creative Planning’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Hold
0
– -$16K – 4735
2016
Q3 		– Hold
0
– – – 3207
2016
Q1 		– Sell
-1
Closed -$90K – 4435
2015
Q4 		$90K Buy
+1
New +$76.4K ﹤0.01% 1696

Other funds holding LABD

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Creative Planning's LABD Position: Q4 2016 in Review

Creative Planning held its Direxion Daily S&P Biotech Bear 3X ETF (LABD) position steady in Q4 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4735.

Creative Planning first reported a position in LABD in Q4 2015 and has held it in 1 quarter since. The position peaked at $90K in Q4 2015. 14 funds tracked by Wall St. Rank hold LABD as of Q4 2016.

  • Creative Planning held 0 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $0 as of Q4 2016.
  • Creative Planning left its Direxion Daily S&P Biotech Bear 3X ETF share count unchanged in Q4 2016.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Creative Planning's portfolio in Q4 2016, its #4735 holding.
  • Creative Planning first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2015 and has held it in 1 quarter since.
  • Creative Planning's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $90K in Q4 2015.
  • 14 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.